BDD Pharma Raises £2M in Funding
Summary
BDD Pharma, an Edinburgh, Scotland, UK-based Integrated drug formulation and clinical trials company, raised £2M in funding. Led by CEO Dr Carol Thomson, BDD is a drug development business, providing pharmaceutical companies with formulation development expertise, on demand GMP manufacture and specialist clinical trial services that combines drug delivery expertise and clinical capabilities to accelerate product development pipelines, enable life cycle management and create new value-added products. It provides onsite CRO and investigative site activities to offer clients a comprehensive integrated solution for conducting early phase clinical trials. BDD’s patented oral drug delivery technology, OralogiK™, enables the timed release of active pharmaceutical ingredients tailored to specific modified-release needs, including sustained, delayed, multiple pulse, and site-targeted release. OralogiK™ supports the development of novel complex formulations and life cycle management opportunities.
Funding
Review available funding amount, funding date, investors, and linked company information related to BDD Pharma Raises £2M in Funding in the interactive ISVWorld profile.